Elevance Health (ELV) Stock Forecast & Price Target

ELV$429.67-0.23 -0.05%
Medical - Healthcare PlansLarge Cap
Compare
Market cap$92.83BEnterprise value$114.57BRevenue (TTM)$201.83BMarket positionTop 25%

Score

39
Bearish
Value
50
Quality
36
Growth
32

Elevance Health Inc. price target

ELV
Low$395.00
Average$466.69
High$523.00
Upside vs current price+8.6%

The average target of $466.69 is +8.6% versus the current ELV price of $429.67.

Elevance Health Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy12
Hold7
Sell0
Strong sell0
ConsensusBuy

22 analysts cover ELV.

Elevance Health Inc. EPS and revenue estimates

ELV shows the next fiscal years with at least three analysts: 2026 EPS $29.05, 2027 EPS $30.25. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$29.05$200.07B
2027$30.25$205.03B

Is Elevance Health Inc. a buy or sell?

Of the 22 analysts covering Elevance Health Inc., 15 rate it a buy (3 strong buy and 12 buy), 7 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The ELV consensus label is Buy, beside 15 buy-side ratings and 0 sell-side ratings.

The average target of $466.69 implies +8.6% versus the current price of $429.67.

Those 22 ratings on ELV are a headcount, and the label on file is Buy.

Reading the Elevance Health Inc. forecast

The ELV target band runs from $395.00 to $523.00. The average inside that band is $466.69.

Set next to the $429.67 ELV quote, that average is +8.6%.

Ratings on the Elevance Health Inc. cluster: 15 of 22 analysts are on the buy side, 7 are at hold, and 0 are on the sell side, and the published consensus is Buy.

ELV targets have not moved much: $473.10 recently, $473.10 across the quarter.

22 analysts publish on ELV, so one note does not swing the average by itself.

Elevance Health Inc. forecast questions

What is the ELV price target?

The published range for ELV is $395.00 to $523.00, with an average of $466.69. That average is +8.6% versus the current price of $429.67.

Is Elevance Health Inc. a buy or sell?

Of the 22 analysts covering Elevance Health Inc., 15 rate it a buy, 7 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the ELV headcount is 15 buy, 7 hold, and 0 sell.

What is the EPS estimate for Elevance Health Inc.?

Analyst EPS estimates for Elevance Health Inc.: 2026 $29.05, 2027 $30.25.

What is the revenue estimate for Elevance Health Inc.?

Analyst revenue estimates for Elevance Health Inc.: 2026 $200.07B, 2027 $205.03B.

How many analysts cover ELV?

22 analysts cover ELV. Their consensus on ELV is Buy, across those 22.

ELV price $429.67 -0.23 -0.05%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener